Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,398 GBX | +0.54% | +2.66% | +16.70% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.70% | 239B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+8.21% | 204B | |
-7.61% | 198B | |
+8.62% | 168B | |
+4.66% | 125B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : JP Morgan reaffirms its Buy rating